AHF Asks State Health Departments & AIDS Directors, Private Insurers to Place Gilead’s New ‘Quad’ Pill on ‘Prior Authorization’ Status
August 17, 2012
SUMMARY:
In what may be an unprecedented move on drug pricing and access, advocates from AIDS Healthcare Foundation, are calling on state AIDS and Medicaid directors as well as a number of private medical insurers nationwide asking them to place Gilead Science’ s new‘ Quad’ pill— a four-in-one, once-daily HIV/AIDS combination tablet— on‘ Prior Authorization’ status on...
The full article is available at AnnuityNews.Com.
SHARE THIS:
USER COMMENTS:
![insider icon](http://s3.amazonaws.com/insurancenews/WebsiteImages/icon_insider.gif") Denotes premium content. Learn more about becoming an Insider here.
|
